Sun Elaine D
SEC insider (Form 3/4/5 filer). CIK 0001805339. Director at RECURSION PHARMACEUTICALS, INC. (RXRX) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SALT LAKE CITY, UT.
Companies Sun Elaine D has filed insider reports for
- RECURSION PHARMACEUTICALS, INC. (RXRX): Director
- DYNAVAX TECHNOLOGIES CORP (DVAX): Director
Sun Elaine D
CIK: 0001805339
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (80.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect88.4K shares- - Feb 10, 2026DVAX
DYNAVAX TECHNOLOGIES CORP
DispositionDirect29.9K shares- - Jun 18, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect11K shares- - Jun 11, 2025DVAX
DYNAVAX TECHNOLOGIES CORP
AwardDirect5.8K shares- - Mar 17, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect36.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  RXRX RECURSION PHARMACEUTICALS, INC. | Award | 88,424 | - | $0 | Direct |
| Feb 10, 2026 |  DVAX DYNAVAX TECHNOLOGIES CORP | Disposition | 29,865 | - | $0 | Direct |
| Jun 18, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 11,008 | - | - | Direct |
| Jun 11, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | Award | 5,758 | - | - | Direct |
| Mar 17, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 36,549 | - | - | Direct |
1-5 of 5 transactions